On the recordJuly 28, 2021
My colleagues and constituents back home often communicate to me that the FDA needs to be less risk-averse.
Source
congress.govMy colleagues and constituents back home often communicate to me that the FDA needs to be less risk-averse.
Curtis emphasizes the need for the FDA to allow greater access to treatments.
Share & report
More from John Curtis
We can do both things. We can be compassionate and we can be fiscally responsible.
The people want change. We all knew what we were getting with President Trump.
I want to give you a compliment, both of you, and just say that over and over again I hear positive feedback about members that work for both BLM and National Park Service on the ground in Utah.